cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Gilead Sciences Inc
163 own
152 watching
Current Price
$77.09
$-0.56
(-0.72%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
96,208.32M
52-Week High
52-Week High
89.74
52-Week Low
52-Week Low
57.165
Average Volume
Average Volume
5.44M
Dividend Yield
Dividend Yield
0.04237
P/E Ratio
P/E Ratio
11.3194
iconMarket Capitalization96,208.32M
icon52-Week High89.74
icon52-Week Low57.165
iconAverage Volume5.44M
iconDividend Yield0.04237
iconP/E Ratio11.3194
What does the Gilead Sciences Inc do?
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in Europe, North America, Asia, South America, Africa, Australia, India, and the Middle East. The company's products include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Vemlidy, Epclusa, Harvoni, Sovaldi, Viread, and Hepsera products for treating liver diseases. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis C virus and hepatitis B virus; hematology/oncology; cardiovascular; and inflammation/respiratory diseases. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company, Janssen R&D Ireland, Japan Tobacco Inc., and Galapagos NV. The company was founded in 1987 and is headquartered in Foster City, California.
Read More
How much money does Gilead Sciences Inc make?
News & Events about Gilead Sciences Inc.
Stock Options Channel
26days ago
Investors in Gilead Sciences Inc (GILD) saw new options become available today, for the June 23rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GILD options chain for the new June 23rd contracts and identified one put and one call contract of particular ...
Accesswire
1month ago
NORTHAMPTON, MA / ACCESSWIRE / April 19, 2023 / Gilead SciencesWhen I came to Gilead in 2019, I did so in part because of the revolutionary way this company thinks about bringing therapies to those who could benefit. Health equity and access are more than goals or ambitions - they're...
Business Wire
1month ago
Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive results from several COVID-19 clinical and real-world evidence studies being presented at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID). A Phase 3 clinical study demonstrated that Veklury...
Accesswire
1month ago
NORTHAMPTON, MA / ACCESSWIRE / April 12, 2023 / Gilead Sciences: Originally published by Gilead SciencesDr. Jeffrey Lazarus was studying at New York University in the late 1980s when he saw first-hand the devastation of the HIV epidemic. Today, as a professor at the CUNY Graduate School of Public...
Benzinga
1month ago
read more...
Frequently Asked Questions
Frequently Asked Questions
What is Gilead Sciences Inc share price today?
plus_minus_icon
Can Indians buy Gilead Sciences Inc shares?
plus_minus_icon
How can I buy Gilead Sciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Gilead Sciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Gilead Sciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Gilead Sciences Inc?
plus_minus_icon
What is today’s market capitalisation of Gilead Sciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Gilead Sciences Inc?
plus_minus_icon
What percentage is Gilead Sciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Gilead Sciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$77.09
$-0.56
(-0.72%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00